<DOC>
	<DOCNO>NCT02563964</DOCNO>
	<brief_summary>Myocardial infarction ( MI ) frequently recur non-ST elevation MI ( NSTEMI ) may relate insufficient vulnerable plaque identification use invasive coronary angiography . Furthermore , natural behaviour vulnerable plaque NSTEMI time relation biomarkers need exploration . More accurate identification assess long-term behaviour vulnerable plaque may improve therapeutic strategy clinical outcome . The investigator hypothesize fully integrated 18Fluoride Sodium-Fluoride ( 18F-NaF ) Positron Emission Tomography/Cardiac Magnetic Resonance imaging ( PET/CMR ) increase ability detect vulnerable plaque compare coronary angiography . This prospective study 33 consecutive patient NSTEMI aim : 1 . Compare coronary vulnerable plaque detection 18F-NaF PET/CMR invasive coronary angiography , 2 . Investigate correlation coronary vulnerable plaque use 18F-NaF PET myocardial infarction use CMR , baseline follow-up , 3 . Examine systemic arterial 18F-NaF-uptake use PET/CMR relation systemic event ( cerebrovascular accident , transient ischemic attack , peripheral arterial disease ) , 4 . Examine relation vulnerable plaque plasma biomarkers .</brief_summary>
	<brief_title>Vulnerable Plaque Imaging NSTEMI</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Prolonged symptom suspect cardiac origin ( angina pectoris angina equivalent ) , presentation cardiac emergency department &lt; 24 hour symptom onset Elevated level highsensitivity troponin T ( &gt; 14ng/L ; initial blood sample presentation second sample 3 hour presentation ) Only patient schedule invasive coronary angiography Age 18 year 85 year Mentally competent Informed write consent Conservatively manage patient schedule invasive coronary angiography Refractory angina ongoing severe ischemia require immediate invasive coronary angiography Patients require invasive coronary angiography &lt; 24 hour admission Hemodynamic instability cardiogenic shock ( mean arterial pressure &lt; 60 mmHg ) Severe heart failure ( Killip Class ≥ III ) ST elevation myocardial infarction ( STelevation 2 contiguous lead : ≥0.2mV men ≥0.15 mV woman lead V2V3 and/or ≥0.1 mV lead new left bundle branch block ) Chest pain highly suggestive noncardiac origin ( judged cardiac emergency department physician/cardiologist ) : ( Suspicion ) acute aortic dissection , acute pulmonary embolism , acute perimyocarditis Life threaten arrhythmias cardiac emergency department prior presentation ( sustain ventricular tachycardia , repetitive nonsustained ventricular tachycardia , ventricular fibrillation , sinoartial atrioventricular block ) Atrial fibrillation ventricular rate ≥100 beat per minute ( bpm ) Tachycardia ( ≥100/bpm ) Angina pectoris secondary anaemia ( &lt; 5.6 mmol/L ) , untreated hyperthyroidism , severe hypertension ( &gt; 200/110 mmHg ) More mild aortic mitral valve calcification stenosis late echocardiography Pregnancy Breast feed woman Life expectancy &lt; 2 year ( malignancy , etc . ) Refusal data storage 15 year end study Participation another investigational study reach primary endpoint Contraindications cardiac magnetic resonance imaging</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Myocardial infarction</keyword>
	<keyword>vulnerable plaque</keyword>
	<keyword>Positron emission tomography ( PET )</keyword>
	<keyword>Cardiac magnetic resonance imaging ( CMR )</keyword>
	<keyword>Biomarkers</keyword>
</DOC>